• S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • May 7 2021
  • Duración: 25 m
  • Podcast

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

  • Resumen

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.